We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$550M
AUM Growth
+$21.3M
Cap. Flow
-$7.01M
Cap. Flow %
-1.27%
Top 10 Hldgs %
36.64%
Holding
133
New
19
Increased
31
Reduced
55
Closed
4

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$10.1M
2
PG icon
Procter & Gamble
PG
+$6.58M
3
ADM icon
Archer Daniels Midland
ADM
+$5.96M
4
ABT icon
Abbott
ABT
+$3.08M
5
AZTA icon
Azenta
AZTA
+$2.52M

Sector Composition

Rank Sector Weight
1 Healthcare 24.11%
2 Industrials 21.96%
3 Technology 18.62%
4 Energy 10.77%
5 Utilities 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEL icon
26
TE Connectivity
TEL
$59.9B
$7.12M 1.29%
81,000
-800
-1% -$73.6K
LGTY
27
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$7M 1.27%
576,705
-16,150
-3% -$244K
NEE icon
28
NextEra Energy
NEE
$183B
$6.88M 1.25%
164,136
-2,268
-1% -$96.5K
ACM icon
29
Aecom
ACM
$9.22B
$6.71M 1.22%
205,500
+14,100
+7% +$465K
TMO icon
30
Thermo Fisher Scientific
TMO
$214B
$6.53M 1.19%
26,750
-290
-1% -$66.7K
BNS icon
31
Scotiabank
BNS
$107B
$6.22M 1.13%
104,384
-500
-0.5% -$29.2K
CGW icon
32
Invesco S&P Global Water Index ETF
CGW
$1.05B
$5.67M 1.03%
162,516
-1,250
-0.8% -$43.5K
XRAY icon
33
Dentsply Sirona
XRAY
$2.75B
$5.34M 0.97%
+141,500
New +$5.89M
HAL icon
34
Halliburton
HAL
$26.4B
$5.22M 0.95%
128,800
+20,050
+18% +$830K
AZTA icon
35
Azenta
AZTA
$1.33B
$5.2M 0.94%
148,335
-76,801
-34% -$2.52M
DGX icon
36
Quest Diagnostics
DGX
$25.9B
$5.15M 0.94%
47,696
-323
-0.7% -$35.4K
GE icon
37
GE Aerospace
GE
$368B
$5.08M 0.92%
93,998
-28,583
-23% -$1.76M
ESBK
38
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$4.97M 0.9%
243,556
+5,034
+2% +$103K
LFCR icon
39
Lifecore Biomedical
LFCR
$164M
$4.88M 0.89%
339,209
-8,150
-2% -$113K
CNDT icon
40
Conduent
CNDT
$245M
$4.67M 0.85%
207,401
-6,626
-3% -$136K
IDA icon
41
Idacorp
IDA
$7.86B
$4.63M 0.84%
46,664
-100
-0.2% -$9.63K
CAMP
42
DELISTED
CalAmp Corp.
CAMP
$4.61M 0.84%
8,367
-279
-3% -$149K
BAX icon
43
Baxter International
BAX
$13.8B
$4.45M 0.81%
57,771
-200
-0.3% -$14.8K
GSK icon
44
GSK
GSK
$104B
$4.32M 0.79%
86,028
+28,160
+49% +$1.43M
EXC icon
45
Exelon
EXC
$46.6B
$4.12M 0.75%
132,223
+1,087
+0.8% +$33.4K
ORBK
46
DELISTED
Orbotech Ltd
ORBK
$3.97M 0.72%
66,842
-1,070
-2% -$66.9K
TYG
47
Tortoise Energy Infrastructure Corp
TYG
$1.09B
$3.66M 0.67%
34,006
-721
-2% -$80.7K
EWC icon
48
iShares MSCI Canada ETF
EWC
$6.17B
$3.62M 0.66%
125,833
-1,700
-1% -$49K
DUK icon
49
Duke Energy
DUK
$98.4B
$3.52M 0.64%
43,933
-300
-0.7% -$24.3K
EPU icon
50
iShares MSCI Peru and Global Exposure ETF
EPU
$543M
$3.19M 0.58%
+86,356
New +$3.28M

Similar funds

John G. Ullman & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, John G. Ullman & Associates held 133 positions worth $550M, up 4% from $529M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

John G. Ullman & Associates's Q3 2018 filing shows 19 new, 31 increased, 55 reduced and 4 closed positions. Its largest new stake was Dentsply Sirona: 141,500 shares worth $5.34M. The largest sale was Johnson & Johnson, an estimated $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q3 2018 buy was Dentsply Sirona: 141,500 shares worth $5.34M.
  • John G. Ullman & Associates added most to Granite Construction in Q3 2018, an estimated $3.63M increase.
  • John G. Ullman & Associates's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $10.1M.
  • John G. Ullman & Associates fully exited Procter & Gamble in Q3 2018, selling an estimated $6.58M.
  • John G. Ullman & Associates's ten largest holdings make up 37% of its $550M portfolio in Q3 2018.
  • John G. Ullman & Associates opened 19 new positions and closed 4 in Q3 2018.
  • John G. Ullman & Associates's portfolio value rose 4% quarter-over-quarter to $550M.

Based on John G. Ullman & Associates's 13F filing for Q3 2018, filed 2 Nov 2018.